Literature DB >> 25138722

Characterizing Pluripotent Stem Cells Using the TaqMan® hPSC Scorecard(TM) Panel.

Jeffrey Fergus1, Rene Quintanilla, Uma Lakshmipathy.   

Abstract

Rapid technological developments for the efficient generation of footprint-free induced pluripotent stem cells (iPSC) enabled the creation of patient-specific iPSC for downstream applications in drug discovery and regenerative medicine. However, the large number of iPSCs, generated from diverse genetic backgrounds using various methods and culture conditions, created a steep challenge for rapid characterization and a demand for standardized methods. Current methods rely on a combination of in vitro and in vivo cellular analyses based on the expression of markers of self-renewal and the ability of the cells to differentiate into cell types representative of the three germ layers as a confirmation of functional pluripotency. These methods, though informative and extensively used, are not ideal for parallel analyses of large numbers of samples and hence not amenable to high-throughput environments. Recently, genetic and epigenetic expression signatures were used to define and confirm cell states, thus providing a surrogate molecular assay that can potentially replace complex in vivo cellular assays such as teratoma formation. In this chapter, we describe a molecular assay for rapid characterization and standardization of pluripotent stem cells. The TaqMan(®) hPSC Scorecard™ Panel is a comprehensive gene expression real-time PCR assay that consists of 94 individual q-PCR assays comprised of a combination of control, housekeeping, self-renewal, and lineage-specific genes. The resulting expression data set is analyzed using cloud-based analysis software that compares the expression pattern against a reference standard composed of multiple functionally validated ESC and iPSC lines. This system was successfully used to test several ESC and iPSC lines in their undifferentiated states to confirm their signatures of self renewal, as well as their terminally differentiates states, via spontaneous differentiation and directed differentiation into specific lineages, to determine the lines' differentiation potential. This genetic analysis tool, together with the flexibility to utilize varying sample inputs and preparation methods, provides a rapid method to confirm functional pluripotency of ESCs and iPSCs.

Entities:  

Mesh:

Year:  2016        PMID: 25138722     DOI: 10.1007/7651_2014_109

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  10 in total

Review 1.  Current methods and challenges in the comprehensive characterization of human pluripotent stem cells.

Authors:  Joanna S T Asprer; Uma Lakshmipathy
Journal:  Stem Cell Rev Rep       Date:  2015-04       Impact factor: 5.739

2.  Using Patient-Specific Induced Pluripotent Stem Cells and Wild-Type Mice to Develop a Gene Augmentation-Based Strategy to Treat CLN3-Associated Retinal Degeneration.

Authors:  Luke A Wiley; Erin R Burnight; Arlene V Drack; Bailey B Banach; Dalyz Ochoa; Cathryn M Cranston; Robert A Madumba; Jade S East; Robert F Mullins; Edwin M Stone; Budd A Tucker
Journal:  Hum Gene Ther       Date:  2016-07-11       Impact factor: 5.695

3.  Epigenetic biomarker to support classification into pluripotent and non-pluripotent cells.

Authors:  Michael Lenz; Roman Goetzke; Arne Schenk; Claudia Schubert; Jürgen Veeck; Hatim Hemeda; Steffen Koschmieder; Martin Zenke; Andreas Schuppert; Wolfgang Wagner
Journal:  Sci Rep       Date:  2015-03-10       Impact factor: 4.379

4.  cGMP production of patient-specific iPSCs and photoreceptor precursor cells to treat retinal degenerative blindness.

Authors:  Luke A Wiley; Erin R Burnight; Adam P DeLuca; Kristin R Anfinson; Cathryn M Cranston; Emily E Kaalberg; Jessica A Penticoff; Louisa M Affatigato; Robert F Mullins; Edwin M Stone; Budd A Tucker
Journal:  Sci Rep       Date:  2016-07-29       Impact factor: 4.379

5.  Preferential Lineage-Specific Differentiation of Osteoblast-Derived Induced Pluripotent Stem Cells into Osteoprogenitors.

Authors:  Casey L Roberts; Silvia S Chen; Angela C Murchison; Rebecca A Ogle; Michael P Francis; Roy C Ogle; Patrick C Sachs
Journal:  Stem Cells Int       Date:  2017-01-30       Impact factor: 5.443

6.  Connective Tissue Growth Factor Promotes Efficient Generation of Human Induced Pluripotent Stem Cell-Derived Choroidal Endothelium.

Authors:  Allison E Songstad; Kristan S Worthington; Kathleen R Chirco; Joseph C Giacalone; S Scott Whitmore; Kristin R Anfinson; Dalyz Ochoa; Cathryn M Cranston; Megan J Riker; Maurine Neiman; Edwin M Stone; Robert F Mullins; Budd A Tucker
Journal:  Stem Cells Transl Med       Date:  2017-05-05       Impact factor: 6.940

7.  Hyperthermia Disturbs and Delays Spontaneous Differentiation of Human Embryoid Bodies.

Authors:  Ji Hyun Kwon; Hyun Kyu Kim; Tae Won Ha; Jeong Suk Im; Byung Hoo Song; Ki Sung Hong; Jae Sang Oh; Jaeseok Han; Man Ryul Lee
Journal:  Biomedicines       Date:  2020-06-26

8.  iPSC model of CHRFAM7A effect on α7 nicotinic acetylcholine receptor function in the human context.

Authors:  Ivanna Ihnatovych; Tapan K Nayak; Aya Ouf; Norbert Sule; Barbara Birkaya; Lee Chaves; Anthony Auerbach; Kinga Szigeti
Journal:  Transl Psychiatry       Date:  2019-02-01       Impact factor: 6.222

Review 9.  Developments in cell culture systems for human pluripotent stem cells.

Authors:  Weiwei Liu; Chunhao Deng; Carlos Godoy-Parejo; Yumeng Zhang; Guokai Chen
Journal:  World J Stem Cells       Date:  2019-11-26       Impact factor: 5.326

10.  A simplified approach for derivation of induced pluripotent stem cells from Epstein-Barr virus immortalized B-lymphoblastoid cell lines.

Authors:  Stephen J Walker; Ashley L Wagoner; Dana Leavitt; David L Mack
Journal:  Heliyon       Date:  2021-04-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.